T. Wu et al. / Advances in Bioscience and Biotechnology 3 (2012) 665-668
Copyright © 2012 SciRes.
668
OPEN ACCESS
X. (2011) Increased prevalence of regulatory T cells in
the lung cancer microenvironment: A role of thymic stro-
mal lymphopoietin. Cancer Immunology, Immunotherapy,
60, 1587-1596. doi:10.1007/s00262-011-1059-6
[11] De Monte, L., Reni, M., Tassi, E., et al. (2011) Intratu-
mor T helper type 2 cell infiltrate correlates with can-
cer-associated fibroblast thymic stromal lymphopoietin
production and reduced survival in pancreatic cancer.
Journal of Experimental Medicine, 208, 469-478.
doi:10.1084/jem.20101876
[12] Pedroza-Gonzalez, A., Xu, K., Wu, T.C., et al. (2011)
Thymic stromal lymphopoietin fosters human breast tu-
mor growth by promoting type 2 inflammation. Journal
of Experimental Medicine, 208, 479-490.
doi:10.1084/jem.20102131
[13] Friend, S.L., Hosier, S., Nelson, A., et al. (1994) A
thymic stromal cell line supports in vitro development of
surface IgM+ B cells and produces a novel growth factor
affecting B and T lineage cells. Experimental Hema-
tology, 22, 321-328.
[14] Quentmeier, H., Drexler, H.G., Fleckenstein, D., et al.
(2001) Cloning of human thymic stromal lymphopoietin
(TSLP) and signaling mechanisms leading to proliferation.
Leukemia, 15, 1286-1292. doi:10.1038/sj.leu.2402175
[15] Pandey, A., Ozaki, K., Baumann, H., et al. (2000) Cloning
of a receptor subunit required for signaling by thymic
stromal lymphopoietin. Nature Immunology, 1, 59-64.
[16] Ziegler, S.F. and Artis, D. (2010) Sensing the outside
world: TSLP regulates barrier immunity. Nature Immu-
nology, 11, 289-293. doi:10.1038/ni.1852
[17] Watanabe, N., Wang, Y.H,, Lee, H.K., et al. (2005) Has-
sall’s corpuscles instruct dendritic cells to induce CD4+
CD25+ regulatory T cells in human thymus. Nature, 436,
1181-1185. doi:10.1038/nature03886
[18] Wang, Y.H. and Liu, Y.J. (2007) OX40-OX40L interac-
tions: A promising therapeutic target for allergic diseases?
The Journal of Clinical Investigation, 117, 3655-3657.
doi:10.1172/JCI34182
[19] Liu, Y.J. (2007) Thymic stromal lymphopoietin and
OX40 ligand pathway in the initiation of dendritic cell-
mediated allergic inflammation. Journal of Allergy and
Clinical Immunology, 120, 238-244.
doi:10.1016/j.jaci.2007.06.004
[20] Yoo, J., Omori, M., Gyarmati, D., et al. (2005) Spontan-
eous atopic dermatitis in mice expressing an inducible
thymic stromal lymphopoietin transgene specifically in
the skin. Journal of Experimental Medicine, 202, 541-549.
doi:10.1084/jem.20041503
[21] Redhu, N.S. and Gounni, A.S. (2011) Function and
mechanisms of TSLP/TSLPR complex in asthma and
COPD. Clinical & Experimental Allergy, 42, 994-1005.
doi:10.1111/j.1365-2222.2011.03919.x
[22] Zhou, B., Comeau, M.R., De Smedt, T., et al. (2005)
Thymic stromal lymphopoietin as a key initiator of aller-
gic airway inflammation in mice. Nature Immunology, 6,
1047-1053. doi:10.1038/ni1247
[23] Al-Shami, A., Spolski, R., Kelly, J., et al. (2005) A role
for TSLP in the development of inflammation in an
asthma model. Journal of Experimental Medicine, 202,
829-839. doi:10.1084/jem.20050199
[24] Olkhanud, P.B., Rochman, Y., Bodogai, M., et al. (2011)
Thymic stromal lymphopoietin is a key mediator of breast
cancer progression. Journal of Immunology, 186, 5656-
5662. doi:10.4049/jimmunol.1100463
[25] Ohara, M., Yamaguchi, Y., Matsuura, K., et al. (2009)
Possible involvement of regulatory T cells in tumor onset
and progression in primary breast cancer. Cancer Immu-
nology, Immunotherapy, 58, 441-447.
doi:10.1007/s00262-008-0570-x
[26] Li, L., Chao, Q.G., Ping, L.Z., et al. (2009) The preva-
lence of FOXP3+ regulatory T-cells in peripheral blood
of patients with NSCLC. Cancer Biotherapy and Radio-
pharmaceuticals, 24, 357-367.
doi:10.1089/cbr.2008.0612
[27] Tokuno, K., Hazama, S., Yoshino, S., et al. (2009) In-
creased prevalence of regulatory T-cells in the peripheral
blood of patients with gastrointestinal cancer. Anticancer
Research, 29, 1527-1532.
[28] Strauss, L., Bergmann, C., Szczepanski, M., et al. (2007)
A unique subset of CD4+CD25highFoxp3+ T cells se-
creting interleukin-10 and transforming growth factor-
beta1 mediates suppression in the tumor microenviron-
ment. Clinical Cancer Research, 13, 4345-4354.
doi:10.1158/1078-0432.CCR-07-0472
[29] Wu, T., Jia, L., Du, R., et al. (2011) Genome-wide analy-
sis reveals the active roles of keratinocytes in oral muco-
sal adaptive immune response. Experimental Biology and
Medicine, 236, 832-843. doi:10.1258/ebm.2011.010307
[30] Bose, A., Chakraborty, T., Chakraborty, K., et al. (2008)
Dysregulation in immune functions is reflected in tumor
cell cytotoxicity by peripheral blood mononuclear cells
from head and neck squamous cell carcinoma patients.
Cancer Immunity, 8, 10.
[31] Agarwal, A., Rani, M., Saha, G.K., et al. (2003) Disregu-
lated expression of the Th2 cytokine gene in patients with
intraoral squamous cell carcinoma. Immunological Inves-
tigations, 32, 17-30. doi:10.1081/IMM-120019205
ABBREVIATIONS
TSLP: Thymic Stromal Lymphopoietin
Th: T Helper
DC: Dentritic Cell
IL-7Rα: IL-7 Receptor α-Chain
TSLPR: TSLP Receptor Chain
Treg: T Regulatory Cell
NKT: Natural Killer T Cells
STAT: Signal Transducer and Activator of Transcription
COPD: Chronic Obstructive Pulmonary Disease
CAF: Cancer-Associated Fibroblast